Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$167,055
+$93,402 QoQ
Shares Held
12,338
+0.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#247
of 626 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ausdal Financial Partners, Inc. holds $34,343,984 across 14 Drug Manufacturers - General names. OGN ranks #14 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,231 | $9,872,508 | |
| 2 | ABBV |
AbbVie Inc.
|
39,096 | $9,838,116 | |
| 3 | JNJ |
Johnson & Johnson
|
18,662 | $4,739,587 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,933 | $3,075,390 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,985 | $2,019,544 | |
| 6 | AMGN |
Amgen Inc
|
2,893 | $1,047,612 | |
| 7 | PFE |
Pfizer Inc
|
41,679 | $1,003,629 | |
| 8 | NVS |
Novartis AG
|
4,509 | $706,649 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $167,055 | 12,338 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $73,653 | 12,296 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $110,102 | 15,356 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $182,232 | 17,063 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $156,090 | 16,125 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $233,400 | 15,675 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $201,721 | 9,745 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||